Although the mechanism by which the glycine substitution in COL1A1 and COL1A2 genes result in short stature remained incompletely understood [48], we and other groups have reported that OI patients with glycine substitution are distinguishable not only by bone fragility but also by short stature [43, 49]. This evidence concerns the gene COL1A2 and osteogenesis imperfecta.